*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Dapagliflozin Impurity 26 is a critical reference standard for the pharmaceutical industry, defined as a specific degradation or synthetic byproduct of Dapagliflozin. It is utilized in method development and validation to ensure drug purity compliance. The compound features the molecular formula <strong>C<sub>18</sub>H<sub>20</sub>O<sub>7</sub></strong> with CAS number <strong>1459096-58-6</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Serves as an analytical standard for HPLC quantification during manufacturing.</li>
<li><strong>R&D:</strong> Supports stability testing to identify degradation pathways in formulations.</li>
<li><strong>Regulatory Compliance:</strong> Facilitates submission dossiers for FDA and EMA impurity profiling.</li>
</ul>
<h3>Precautions</h3>
<p>Store strictly below <strong>-20°C</strong> in a desiccated environment to prevent hydrolysis. Handle only within certified fume hoods using appropriate PPE. This material is intended solely for research and quality control purposes, not for clinical administration.</p>